Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Karpf-Wissel

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Deutsche Medizinische Wochenschrift (1946)|March 7, 2013
[Hemoptysis--targets in diagnostic and therapy]K Darwiche, R Karpf-Wissel, L Freitag
Pneumologie (Stuttgart, Germany)|April 21, 2021
K Darwiche, R Karpf-Wissel, M Steindor, et al.
Lung|August 31, 2022
Comparison of a 22G Crown-Cut Needle with a Conventional 22G Needle with EBUS Guidance in Diagnosis of SarcoidosisJ Wälscher, E Büscher, F Bonella, et al.
Lung Cancer (Amsterdam, Netherlands)|February 25, 2015
HER2 expression and markers of phosphoinositide-3-kinase pathway activation define a favorable subgroup of metastatic pulmonary adenocarcinomasH Reis, T Herold, S Ting, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Deutsche Medizinische Wochenschrift (1946)|March 7, 2013
[Hemoptysis--targets in diagnostic and therapy]K Darwiche, R Karpf-Wissel, L Freitag
Pneumologie (Stuttgart, Germany)|April 21, 2021
K Darwiche, R Karpf-Wissel, M Steindor, et al.
Lung|August 31, 2022
Comparison of a 22G Crown-Cut Needle with a Conventional 22G Needle with EBUS Guidance in Diagnosis of SarcoidosisJ Wälscher, E Büscher, F Bonella, et al.
Lung Cancer (Amsterdam, Netherlands)|February 25, 2015
HER2 expression and markers of phosphoinositide-3-kinase pathway activation define a favorable subgroup of metastatic pulmonary adenocarcinomasH Reis, T Herold, S Ting, et al.
Pageof 1